Theravance Biopharma TBPH Business Segments — Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's business segments — operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's business segments — operating income?
- Theravance Biopharma (TBPH) reported business segments — operating income of -$9.48M in Q1 2026.
- How has Theravance Biopharma's business segments — operating income changed year-over-year?
- Theravance Biopharma's business segments — operating income increased by 34.3% year-over-year, from -$14.43M to -$9.48M.
- What does business segments — operating income mean?
- This metric represents the profit or loss generated from the core business operations of the segment, calculated by subtracting operating expenses from segment revenue. It serves as a primary indicator of the segment's operational efficiency and its ability to generate sustainable earnings before financing and tax considerations.